nach oben

Erschienen in:

01.09.2013 | Original Article

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder

verfasst von: Vik Khullar, Daniela Marschall-Kehrel, Montserrat Espuna-Pons, Con J. Kelleher, Shannon E. Tully, Elisabeth C. Piault, Linda Brubaker, Aino Fianu-Jonasson, David Weinstein, Agneta Bergqvist, Marion Kvasz

Erschienen in: International Urogynecology Journal | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The Self-Assessment Goal Achievement (SAGA) questionnaire is a patient-completed instrument designed to assess goal attainment in the behavioral or pharmacologic treatment of lower urinary tract symptoms (LUTS), including overactive bladder (OAB). The SAGA questionnaire allows patients to identify and rank the importance of treatment goals before treatment is initiated; the follow-up SAGA questionnaire quantifies the achievement of these patient-identified goals. The objective of this qualitative research was to confirm the content validity of the German, Spanish, Swedish, and English (UK) language versions of the SAGA questionnaire in patients with OAB with or without other LUTS.

Methods

The SAGA questionnaire was translated to each language in accordance with a well-established forward and backward harmonization method. Patient interviews were then conducted according to a cognitive debriefing methodology. Qualitative analysis of patients’ input allowed assessment of content validity of each linguistically adapted SAGA questionnaire.

Results

All patients (n = 29; six to eight per targeted country) found the SAGA questionnaire easy to understand and to complete. Most patients completed the nine prespecified (fixed) treatment goals and were able to add up to five personal goals in the open-ended portion and rate each goal by importance. Differences were identified in how the various languages communicated some of the concepts assessed with the SAGA questionnaire. Rewording of the translated versions of the questionnaire was necessary in some cases.

Conclusions

This linguistic content validation study in four European languages indicates that SAGA is a comprehensive, easy-to-understand, and relevant questionnaire for patient-completed evaluation of LUTS/OAB symptoms and treatment goal attainment.

Nitti VW, Kopp Z, Lin AT, Moore KH, Oefelein M, Mills IW (2010) Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol Urodyn 29:652–657PubMedCrossRef

Shah S, Nitti VW (2009) Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol 11:196–202PubMed

Marschall-Kehrel D, Roberts RG, Brubaker L (2006) Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 68(suppl 2A):29–37PubMedCrossRef

Dmochowski RR, Newman DK (2007) Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 23:65–76PubMedCrossRef

MacDiarmid S, Rosenberg M (2005) Overactive bladder in women: symptom impact and treatment expectations. Curr Med Res Opin 21:1413–1421PubMedCrossRef

Kiresuk TJ, Lund SH, Larsen NE (1982) Measurement of goal attainment in clinical and health care programs. Drug Intell Clin Pharm 16:145–153PubMed

European Medicine Agency (2004) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products; EMEA/CHMP/EWP139391/2004. London. www.emea.eu.int. Cited October 12, 2011

US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) (2009) Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Cited October 12, 2011

Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M et al (2010) Patient-reported reasons for discontinuing overactive bladder medication. BJU Int 105:1276–1282PubMedCrossRef

10.

Burgio KL, Brubaker L, Richter HE, Wai CY, Litman HJ, France DB et al (2010) Patient satisfaction with stress incontinence surgery. Neurourol Urodyn 29:1403–1409PubMedCrossRef

11.

Choo MS, Doo CK, Lee KS (2008) Satisfaction with tolterodine: assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study). Int J Clin Pract 62:191–196PubMedCrossRef

12.

Diokno AC, Sand PK, Macdiarmid S, Shah R, Armstrong RB (2006) Perceptions and behaviours of women with bladder control problems. Fam Pract 23:568–577PubMedCrossRef

13.

Coyne KS, Tubaro A, Brubaker L, Bavendam T (2006) Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts. Urology 68:9–16PubMedCrossRef

14.

Khan MS, Chaliha C, Leskova L, Khullar V (2005) A randomized crossover trial to examine administration techniques related to the Bristol female lower urinary tract symptom (BFLUTS) questionnaire. Neurourol Urodyn 24:211–214PubMedCrossRef

15.

Smith AL, Nissim HA, Le TX, Khan A, Maliski SL, Litwin MS et al (2011) Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology 77:55–59PubMedCrossRef

16.

Wyman JF, Harding G, Klutke C, Burgio K, Berriman S, Vats V et al (2010) Contributors to satisfaction with combined drug and behavioral therapy for overactive bladder in subjects dissatisfied with prior drug treatment. J Wound Ostomy Continence Nurs 37:199–205PubMedCrossRef

17.

Brubaker L, Khullar V, Piault E, Evans CJ, Bavendam T, Beach J et al (2011) Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire. Int Urogynecol J 22:937–946PubMedCrossRef

18.

Chapple CR, Rosenberg MT, Brenes FJ (2009) Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome. BJU Int 104:960–967PubMedCrossRef

19.

Fianu-Jonasson A, Brubaker L, Kelleher C, Khullar V, Bitoun CE, Weinstein D, et al (2009) Understanding Swedish patients’ expectations for treatment of their urinary symptoms. Paper presented at Nordic Urogynecological Association, Reykjavik, Iceland, May 14–16, 2009

20.

Brubaker L, Woodson K, Beach J, Piault E, Wennberg C, Yeh Y, et al (2009) Self-Assessment Goal Achievement Questionnaire: Baseline results of a pilot study in U.S. subjects with lower urinary tract symptoms or overactive bladder. Paper presented at Society of Urologic Nurses and Associates, Chicago, IL, Oct 2–5, 2009

21.

Piault E, Doshi S, Brandt BA et al (2012) Linguistic validation of translation of the Self-Assessment Goal Achievement (SAGA) questionnaire from English. Health Qual Life Outcomes 10:40PubMedCrossRef

22.

Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M et al (2009) Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Value Health 12:430–440PubMedCrossRef

23.

Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A et al (2005) Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104PubMedCrossRef

24.

Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D et al (2003) Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6:522–531PubMedCrossRef

25.

Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K (2008) Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 101:1381–1387PubMedCrossRef

26.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49PubMedCrossRef

27.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4–20PubMed

28.

Irwin DE, Milsom I, Kopp Z, Abrams P (2008) Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 53:1029–1037PubMedCrossRef

29.

Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D et al (2011) Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract 65:567–585PubMedCrossRef

Titel: European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder
verfasst von: Vik Khullar
Daniela Marschall-Kehrel
Montserrat Espuna-Pons
Con J. Kelleher
Shannon E. Tully
Elisabeth C. Piault
Linda Brubaker
Aino Fianu-Jonasson
David Weinstein
Agneta Bergqvist
Marion Kvasz
Publikationsdatum: 01.09.2013
Verlag: Springer London
Erschienen in: International Urogynecology Journal / Ausgabe 9/2013
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-012-2039-x

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2013

Comparison of two scoring systems for diagnosing levator ani muscle damage

Expectant management of cystotomy at the time of midurethral sling placement: a retrospective case series

Single-incision sling compared with transobturator sling for treating stress urinary incontinence: a randomized controlled trial

Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder

Female urethral dilation

How often does detrusor overactivity cause urinary leakage during a stress test in women with mixed urinary incontinence?

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie